Brixner D, Oderda G, Biskupiak J, Burgoyne DS, Avey SG, Feldman SR. The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab. Am Health Drug Benefits. 2019 Feb; 12(1):22-26.